Systemic treatment of melanoma has changed rapidly since the introduction of ipilimumab in 2011. In 10 years, 9 new drugs have been approved for unresectable melanoma, along with 4 new approvals in the adjuvant setting. To provide guidance to clinicians regarding the use of...
Systemic therapy for unresectable/metastatic cutaneous melanoma: ASCO guideline
